Genmab A/S Annual Shareholders Meeting Transcript
/-
Good afternoon, and welcome to Genmab's 2023 Annual General Meeting. We are pleased to once again see so many of you here in person, and welcome also to those of you that are joining us via webcast.
I'm Deirdre Connelly, Chair of Genmab's Board of Directors. I would like to begin by introducing the other members of our Board: Deputy Chair, Pernille Erenbjerg; Paolo Paoletti; Anders Gersel Pedersen; and Elizabeth O'Farrell. We also have 3 employee Board members. These are: Martin Schultz; Takahiro Hamatani; and Mijke Zachariasse.
Next, our company's executive managers, the heavy lifters: Jan van de Winkel, our CEO; Anthony Pagano, our Chief Financial Officer; Judith Klimovsky, our Chief Development Officer; Anthony Mancini, our Chief Operating Officer; Tahi Ahmadi, Chief Medical Officer; Birgitte Stephensen, our Chief Legal Officer; Chris Cozic, our Chief People Officer; and Martine van Vugt, Chief Strategy Officer.
To officially start the proceedings for today's meeting, I would
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |